Seattle, WA, United States of America

Yu Sun

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inventor Yu Sun: Pioneering Advancements in IL-23 Antigen Binding Proteins

Introduction

Yu Sun, based in Seattle, WA, is an accomplished inventor with a remarkable portfolio of 4 patents. His work primarily revolves around innovative solutions in the field of biotechnology, particularly focusing on antigen binding proteins that target human IL-23. His contributions have significant implications for diagnostic and therapeutic applications in medicine.

Latest Patents

Among his notable inventions are two significant patents relating to human IL-23 antigen binding proteins. These patents provide novel antigen binding proteins that effectively bind to the human IL-23 protein. Yu's work also includes nucleic acids that encode the antigen binding proteins, as well as vectors and cells capable of expressing these proteins. The applications of IL-23 antigen binding proteins unveiled in his patents are crucial for advancing diagnostic methods and therapeutic strategies targeting inflammatory diseases.

Career Highlights

Yu Sun currently works at Amgen Inc., a leading biotechnology company renowned for its innovative approaches to medical solutions. His contributions in the organization highlight his role in driving research and development within the field of immunology, showcasing his commitment to enhancing human health through scientific advancements.

Collaborations

Throughout his career at Amgen, Yu has collaborated with talented professionals, including Jennifer E. Towne and Yu Zhang. These collaborations have fostered a dynamic environment for innovation, allowing the team to leverage their combined expertise and creativity.

Conclusion

Yu Sun stands out as a leading inventor in the biotechnology sector, with his influential patents aimed at improving therapeutic and diagnostic tools targeting human IL-23. His journey at Amgen Inc. and collaborations with his impressive colleagues reflect his dedication to pushing the boundaries of scientific discovery. As the field of immunology continues to evolve, Yu's contributions are likely to play a pivotal role in shaping future medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…